Medical Affairs: Advancing Access Through Medical Partnerships

Medical Affairs is increasingly important as scientific discoveries rapidly change healthcare standards. They play a crucial role in clearly communicating new innovations and speeding up their availability.

Yet companies focused on larger markets often overlook medical engagement to support ethical product launches in lower-middle income countries.

Established in 1999, Swiss-based Delta Medical bridges this divide through dedicated medical affairs resources directly building trust with regional healthcare communities across:

13 Emerging market countries

Specialty and orphan disease portfolios

Evidence supporting differentiation

We ease manufacturer market entry through scientific exchange, safety vigilance and stakeholder education – laying foundations for launch momentum.

Our Medical Affairs Capabilities Span:

Congress presence establishing legitimacy

Clinical trial facilitation demonstrating localized outcomes

Compliance enforcement preventing perception erosion

Key opinion leader access building prescriber confidence

We operate in Armenia, Azerbaijan, Belarus, Georgia, Kazakhstan, Kyrgyzstan, Moldova, Mongolia, Russia, Tajikistan, Turkmenistan, Ukraine and Uzbekistan.

Delta Medical enables partner expansion through specialized medical affairs proficiencies developed over the past two decades.

Committed to Medical Dialogue on Unmet Needs

In medical affairs, we focus on understanding the specific patient groups, the severity of their conditions, and the infrastructure needed for specialist care. This helps us to create effective launch strategies, ensuring treatments are accessible, affordably priced, and well-positioned in the market.

Ethical Response to Specialized Medical Inquiries

Dealing with rare diseases and specific treatments naturally leads to complex questions about the implications and challenges that specialized doctors face. These include deciding the right use of treatments and managing what patients expect. Delta Medical’s medical affairs team help navigate these uncertainties by:

Literature review contextualizing latest data
Safety signal vigilance monitoring uncommon adverse events
Ongoing inquiry monitoring should new dynamics emerge

We ease manufacturer entry by building foundations of trust with regional practitioner communities – conveying consultation not promotion first through medical exchange.

Tackling Inquiries with Precision and Personalization

Requests triaged based on complexity, sensitivity and required turnaround speeds
Junior advisors supported by veteran therapeutic leads with relevant publications
We personalize responses to address the specific concerns highlighted in each initial inquiry.

We understand reputations rely on responsiveness. Thus inquiries received digitally before noon receive initial confirmatory replies same day.

Conveying Context Alongside Content

Beyond answering questions alone, our medical information responses convey contextual insights aiding interpretation and application:

– Summaries of latest international congresses highlighting related presentations
– Research methodology limitations providing grounded perspective
– Supporting evidence appraisals enabling risk-benefit balancing

Thus we progress science through exchange – not claims detached from dialogue.

Managing Information Ethics Through Policy Governance

Delta Medical has implemented strict medical information governance policies to balance the increased access from data democratization with the risks of misuse:

– EU GDPR standards for responsible information handling
– Uniform employee training requirements on ethics protocols
– Oversight procedures ensuring adherence via sample case audits

We understand physician trust remains hard fought but easily forfeited without disciplined safeguards preempting even perceptions of overreach.

Commitments to our customers include:

– Anonymize sources to protect privacy.
– Provide factual replies, free from influence.
– Continue exchanges only if beneficial to all involved.

Delta Medical expands regional opportunities for partners by fostering a culture of scientific collaboration focused on enhancing lives, with a trust that outcomes will naturally develop over time.

Advancing Patient Safety in Clinical Medicine

As guardians for patient wellbeing, our specialists guide partners upholding ethical obligations across:

Pharmacovigilance and Safety Surveillance

Enhancing Salesforce Competency with Ongoing Field Medical Training

Introducing specialized treatments for rare diseases depends on field medical teams teaching doctors how to choose the right patients, manage treatment protocols, monitor for side effects, and access assistance networks to encourage their use.

Delta Medical prepares field medical, scientific and marketing staff through immersive training across:

Disease State Knowledge

– Diagnostic guidance to identify appropriate subpopulations
– Clinical trial insights conveying product administration requirements
– Latest guidelines for standard-of-care in target indications

Thus scientific discussion anchors in properly cultivated mastery of the core health conditions.

Messaging and Compliance

– Local policies for balanced and substantiated information.
– Reporting to authorities in case of adverse events.
– Using promotional materials approved by regulators.

This ensures ethical progress in field exchanges, adapting to changing compliance rules.

Consultative Selling Skills

– Asking questions to find unmet needs.
– Building trust by focusing on non-product interactions initially.
– Communicating value effectively across various digital channels.

Delta Medical trains field consultants to blend scientific knowledge with empathy, fostering in-depth discussions that match treatments to patient needs, not just products.

Continuous Development Evaluation

Ongoing ride-alongs provide field operations visibility to:

– Audit ethical adherence through engagement scoring evaluations
– Identify knowledge capability gaps for skills strengthening
– Share best practices across teams to multiply impact faster

We prioritize continuous learning in field education, focusing on patient needs from clinical trial recruitment to long-term therapy management.

Medical Leadership Cooperation

Adoption of treatments won’t increase access if there’s a lack of support systems, such as training for key opinion leaders (KOLs), specialist training centers, or advanced diagnostics for identifying patients.

Thus Delta Medical medical consultants broaden engagement through:

KOL Partnership Cultivation

– Steering committees contribute to launch planning with scientific insights.
– Collaborating on research projects for new clinical findings.
– Expanding networks with leading international experts.

This approach ensures that influential voices drive market efforts with validated information.

Center of Excellence (COE) Formation

– Developing regional blueprints for diagnostics and patient care.
– Streamlining clinical processes to connect disjointed healthcare journeys.
– Gaining recognition through partnerships with health authorities.

This collective approach raises regional standards to match well-established best practices.

Clinician Society Relationship Development

– Offering leadership programs to enhance skills beyond just pharmaceuticals.
– Regular interaction at local events and regional conferences.
– Collaborating on statements to address broader access needs.

Progress is made through partnerships, ensuring a constant presence.

Delta Medical’s medical teams are supported by a well-developed ecosystem, creating a ready environment for change and speeding up adoption when products arrive.

For we know, medicine advances only when infrastructure and beliefs progress in parallel – guiding usage appropriately – elevating standards universally.

Safeguarding Integrity Through Proactive Governance

Delta Medical places a high priority on maintaining its perceived independence from commercial influences to preserve physician trust and ensure ongoing collaboration.

To safeguard this integrity, the company has implemented proactive governance measures, including:

Financial Transparency

– Reporting on consultant contracts similar to the Sunshine Act.
– Monitoring spending limits with stakeholders to avoid overdependence.
– Requiring attestations to follow guidelines for partnership boundaries.

Thus we prevent inference of conflicts risking trust erosion.

Oversight Integration

– Specialists must follow the decisions of the ethics review board.
– Legal and compliance departments work together on new issues.
– Adhering to universal privacy principles to protect information security.

Thus we foster collaboration but intervene should boundaries blur.

Associations and Accreditations

– Leadership roles in several medical affairs alliances
– Member of the Swiss Biotech Association
– Routine external audits on fair balance and bias

Because excellence demands external validation beyond promises alone.

Activating Patient and Payer Partnerships

Driving availability involves more than just clinical support. Therefore, Delta Medical engages with patient groups and payer advisory boards, incorporating real-life experiences and financial considerations into early launch planning.

Patient Community Engagement

– Regular meetings to understand patient views on value messaging.
– Setting priorities for necessary infrastructure investments.
– Collaborating on disease education to improve understanding.

This approach ensures that scientific developments are aligned with the real-life experiences of patients from the beginning.

Payer Policy Participation

Delta Medical engages in Payer Policy Participation by:

– Planning cycles for health technology assessment (HTA) dossiers, focusing on value evidence.
– Modeling scenarios to understand budget impacts and optimize access.
– Consulting after directives to improve future submissions.

This approach ensures decisions are well-informed, considering both clinical and system implications for sustainable solutions.

Delta Medical: Fostering Trust and Ethics in Healthcare

Delta Medical builds strong foundations by:

– Collaborating to communicate complex issues.
– Inherently upholding ethical standards.
– Establishing essential elements before treating patients, planting trust, capabilities, and infrastructure where doubt once existed.

These efforts ensure our partnerships create fair paths to access, marked by patience and continuous presence.

Advancing Availability Through Specialized Medical Partnerships

Specialty medicine leaders must train their staff to ethically share complex information with regional doctors and invest in additional resources to improve access.

Often, companies focus on wealthier markets and overlook the importance of medical partnerships in lower-middle income countries, where there is high need but limited affordability.

Since 1999, Switzerland’s Delta Medical has been working to bridge this gap by dedicating resources to build trust in healthcare communities across 13 emerging Eurasian regions that are often ignored.

Delta Medical Provides:

Consultative Scientific Exchange Rooted in Need Identification

Responsible Evidence Generation for Localized Decision Making

Compliant Multi Stakeholder Engagement Accelerating Outcomes

Delta Medical helps global manufacturers maintain ethical standards in science, patient focus, and continuous care, now reaching populations that previously had limited access to new medical innovations.

McKinsey research suggests that over 90% of global health growth in the next decade will be in mid-income economies. Therefore, combining scientific and commercial partnerships is essential for more equitable healthcare access in the 2020s and beyond.

Delta Medical rises to this challenge with a focus on presence and patience, blending commercial launch expertise with medical dedication, ensuring proper use of treatments while expanding opportunities.

Partner with Delta Medical to Expand Access in Russia, Ukraine and Eurasia Through Specialized Medical Affairs.